Depression News and Research

Latest Depression News and Research

Study: Parkinson’s disease undermines language processing ability in Dutch native speaker patients

It is becoming more generally known that Parkinson's disease not only influences a patient's motor functions. Patients often also suffer from depression, fear and incontinence, for example. However, the disease also undermines the language processing ability. University of Groningen researcher Katrien Colman has found clear indications of this in Dutch native speaker patients.

9 Feb 2011

New study finds income-related inequalities impact mental health

Due to the recent economic crisis, an increase of health inequalities between socio-economic groups has been noticed in both developed and developing countries.

9 Feb 2011

Urocortin system plays central role in regulating stress responses

Post-traumatic stress disorder can affect soldiers after combat or ordinary people who have undergone harrowing experiences. Of course, feelings of anxiety are normal and even desirable - they are part of what helps us survive in a world of real threats. But no less crucial is the return to normal - the slowing of the heartbeat and relaxation of tension - after the threat has passed.

9 Feb 2011

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

Metabolon, the leader in metabolomics, biomarker discovery and analysis, announced today the grant of US Patent No. 7,884,318 entitled "Systems, Methods, and Computer-Readable Medium for Determining Composition of Chemical Constituents in a Complex Mixture".

8 Feb 2011

ADHD kids often suffer from other mental ailments: Study

As many as two thirds of American children suffering from attention-deficit/hyperactivity disorder, ADHD, also suffer other mental health and developmental conditions, such as learning disabilities and anxiety says a new study.

8 Feb 2011

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Using a unique and relatively simple cell-based fluorescent assay they developed, scientists with the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California, Berkeley have identified a means by which fluoxetine, the active ingredient in Prozac, suppresses the activity of the TREK1 potassium channel.

8 Feb 2011

Study identifies genetic variation linked with increased risk of major depression

Numerous studies have shown that the brain molecule neuropeptide Y (NPY) helps to restore calm after stressful events. A team of University of Michigan-led researchers has now found that people whose genes predispose them to produce lower levels of NPY are more responsive to negative stimuli in key brain circuits related to emotion - and are therefore less resilient in the face of stress and may be at higher risk for developing a major depressive disorder.

8 Feb 2011

NIMH awards two BUSM members with BRAINS grant for innovative research on mental disorders

Two Boston University School of Medicine faculty members, Pietro Cottone, PhD, an assistant professor of pharmacology and psychiatry and Michael Silverstein, MD, an associate professor of pediatrics, were each awarded the prestigious National Institute of Mental Health Biobehavioral Research Awards for Innovative New Scientisits grant with ten other investigators from around the country.

7 Feb 2011

State Roundup: Setting up health insurance exchanges; Community-based clinics cuts; Autism legislation; End-of-life care

The board of the Health Benefit Exchange is going to be small and mighty. ... This exchange will concentrate the health insurance buying power of millions of Californians, and will be the central force in implementing national health care reform in California (Gorn, 2/4).

7 Feb 2011

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

AstraZeneca and Targacept, Inc. today announced initiation of a Phase 2b clinical trial of TC-5214, a nicotinic channel blocker, as a "switch" monotherapy treatment for patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant therapy. This study is in addition to the companies' Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD.

7 Feb 2011

WINCS device can detect and measure serotonin levels in brain: Mayo Clinic

Mayo Clinic researchers have concluded that, through deep brain stimulation, a Wireless Instantaneous Neurotransmitter Concentration System can detect and measure serotonin levels in the brain. The findings suggest that in the future such measurements of serotonin may help establish a therapeutic mechanism of deep brain stimulation for psychiatric disease.

5 Feb 2011

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

Amgen and Pfizer Inc. today announced results from a new trial that demonstrated Enbrel significantly improved scalp involvement in adult patients with moderate to severe plaque psoriasis, compared with placebo. The data will be presented today at the 69th Annual American Academy of Dermatology meeting in New Orleans, La.

5 Feb 2011

U-M Medical School earns $368.7 million in NIH research funding during federal fiscal year 2010

University of Michigan Medical School physicians and scientists earned more than $368.7 million in National Institutes of Health research funding in federal fiscal year 2010, according to NIH data. In all, the School's faculty brought in $481.8 million in research funding from all sources in U-M fiscal year 2010.

5 Feb 2011

Research provides new clues to understand link between deficits of AGPO-3, depression

The link between deficits of omega-3 poly-unsaturated fatty acids and the onset of depressive disorders is not new in the medical field. However, what has not been known until now is the brain mechanism by which diet can condition mental health to a certain extent.

5 Feb 2011

Systematic review confirms benefits of taking exercise in natural environment

A systematic review carried out by a team at the Peninsula College of Medicine and Dentistry has analysed existing studies and concluded that there are benefits to mental and physical well-being from taking exercise in the natural environment. Their findings are published in the leading research journal Environmental Science and Technology today, 4th February 2011.

5 Feb 2011

Ascend Health opens Mother-Infant Outpatient Program to treat post-partum depression

Ascend Health Corporation, through Cedar Hills Hospital, announced the opening of the Mother-Infant Outpatient Program, the first in the Pacific Northwest region where new mothers can receive treatment with their children in a safe, caring and convenient setting. Cedar Hills Hospital is a facility of Ascend Health Corporation.

5 Feb 2011

HPV vaccine can prevent 90% of genital warts in men: Study

The vaccine for human papillomavirus can prevent 90 percent of genital warts in men when offered before exposure to the four HPV strains covered by the vaccine, according to a new multi-center study led by H. Lee Moffitt Cancer Center and UCSF.

4 Feb 2011

Study finds increased prescription drug abuse among teens

Illicit drugs like marijuana, cocaine and heroin have always been a parent's nightmare. But perfectly legal and easily accessible prescription medications are now the recreational drugs of choice for many teenagers, prompting physicians at Johns Hopkins Children's Center to urge pediatricians to screen specifically for their abuse during routine visits.

4 Feb 2011

U-M conference to focus on detection of mental illness during high stakes college years

The annual University of Michigan's Depression on College Campuses conference, held March 28-29, will focus on detection of mental illness during the high stakes college years.

3 Feb 2011

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Shionogi-ViiV Healthcare, LLC announced today that the first patient has entered the clinical study, SINGLE (ING114467), designed to support a new fixed-dose combination (FDC) therapy for the treatment of HIV.

3 Feb 2011

Depression News and Research

Latest Depression News and Research

Study: Parkinson’s disease undermines language processing ability in Dutch native speaker patients

New study finds income-related inequalities impact mental health

Urocortin system plays central role in regulating stress responses

USPTO issues patent for Metabolon's UHPLC/MSn-based analytical platform

ADHD kids often suffer from other mental ailments: Study

TREK1 activity offers a key target for fluoxetine and other antidepressant drugs

Study identifies genetic variation linked with increased risk of major depression

NIMH awards two BUSM members with BRAINS grant for innovative research on mental disorders

State Roundup: Setting up health insurance exchanges; Community-based clinics cuts; Autism legislation; End-of-life care

AstraZeneca, Targacept commence TC-5214 Phase 2b clinical trial for major depressive disorder

WINCS device can detect and measure serotonin levels in brain: Mayo Clinic

Amgen, Pfizer present Enbrel new trial results against psoriasis at 69th AAD meeting in New Orleans, LA

U-M Medical School earns $368.7 million in NIH research funding during federal fiscal year 2010

Research provides new clues to understand link between deficits of AGPO-3, depression

Systematic review confirms benefits of taking exercise in natural environment

Ascend Health opens Mother-Infant Outpatient Program to treat post-partum depression

HPV vaccine can prevent 90% of genital warts in men: Study

Study finds increased prescription drug abuse among teens

U-M conference to focus on detection of mental illness during high stakes college years

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in